China News Service, March 23. According to Russian satellite network on the 23rd, citing public opinion polling agency YouGov (YouGov), a poll conducted by the British public opinion survey company (YouGov), some countries have found that complications may occur after vaccination with AstraZeneca and have stopped them After using the news, European people's trust in this vaccine has dropped significantly.

　　The report pointed out that compared with the questionnaire in February 2021, the number of people in France, Germany, Italy and Spain who trust AstraZeneca vaccines has decreased, thinking it may be unsafe.

For example, in February, 43% of Germans thought this vaccine was safe; 40% thought it was unsafe; and now most (55%) think it is unsafe, and only 32% oppose it.

Data map: A woman working in a nursing home in Berlin, Germany, received the new crown vaccination.

　　In February, 43% of respondents in France considered the AstraZeneca vaccine to be unsafe; 33% believed it was safe; trust in the vaccine dropped sharply in March: 61% thought it was unsafe; only 23% believed it .

　　Respondents in Italy and Spain previously believed that the vaccine was safe (54% and 59%, respectively); in March this indicator fell to 36% and 38%, respectively, and 43% of respondents believed that the vaccine is likely to be unsafe. And 59%.

　　Sweden and Denmark joined the survey in March: 43% of Sweden think the vaccine is likely to be effective, 34% of the respondents think it is unsafe; 42% of the Danish respondents think it is unsafe, and 42% think it is safe; Interviewers agreed that Pfizer and Modena vaccines are safer.

Data map: Belgian medical staff are preparing for the new crown vaccination work.

　　The poll was conducted between March 15th and 18th. A total of 1672 Britons, 2024 Germans, 1022 French, 1016 Italians, 1050 Spaniards, 1004 Danes and 1017 were in total. Swedes participate.

　　The European Medicines Agency (EMA) previously reported that it is investigating the occurrence of thromboembolic complications after a batch of AstraZeneca vaccines in some European member states.

Some EU countries have suspended the use of AstraZeneca vaccine.

The bureau recommended the continued use of the AstraZeneca vaccine on March 18, and then a series of countries began to re-vaccinate.